半野调强照射技术在食管癌放疗中的应用探讨

doi:10.3760/cma.j.cn113030-20210906-00352

Abstract
Figure/Table
References(21)
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract Objective To explore a new technique for lung dose reduction in esophageal cancer radiotherapy based on the dose distribution characteristics of the half-field combined with intensity-modulated radiotherapy (IMRT) technique. Methods A three-dimensional water tank was used to measure the dose distribution at the edge of the symmetrical field and half-field, which was then compared and analyzed. Twenty patients with the middle and lower thoracic esophageal cancer receiving radiotherapy with prescription doses of 50.4-60.0Gy were selected. Based on the Varian Vital beam linear accelerator and Eclipse planning system, flattening filter (FF) technique symmetrical field and half-field beam design and the flattening filter-free (FFF) technique symmetrical field and half-field design were adopted to compare and analyze various dose data and treatment MU numbers for the target area and the endangered organs. The field settings were chosen in the front 1 and back 4 mode. Results Compared with the symmetrical field plan, the half-field plan significantly improved the irradiated dose to the lung with a statistically significant difference (P<0.05), and the half-field FFF was slightly better than the half-field FF mode. Compared with the total lung V5Gy, V20Gy, V30Gy, and Dmean dosimetric parameters (Gy), the FF symmetric field and FFF half-field were (49.64±5.39)% vs.(42.70±5.53)%,(15.99±3.93)% vs.(13.32±3.06)%,(9.24±2.77)% vs.(8.50±2.62)%, and (10.45±1.76)% vs.(9.50±1.53)%, respectively. There was a significant reduction in the volume dose values for all structures of the lung (all P<0.05). For other comparative data, the irradiated dose for the heart of the symmetrical field was better than that of the half-field mode (P<0.05), and the differences in conformity index (CI) and homogeneity index (HI), number of treated MU, and spinal cord associated with the target area were not statistically significant (all P>0.05). Conclusions During radiotherapy for esophageal cancer, target area coverage and dose volume data of the lung are the main parameters affecting the efficacy and side effects. IMRT treatment based on the half-field mode can give full play to the advantages of half-field and IMRT, and significantly improve the irradiated dose to the lung, which can offer an additional clinical option.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Liu Yang
	Ding Danhong
	Wei Shengtao
	Wang Yingying
	Li Dingjie

Key words： Half-field irradiation Flattening filter Flattening filter free Esophageal neoplasm/intensity-modulated radiotherapy

Received: 06 September 2021

Fund:Key Science and Technology Research Project of Henan Provincial Department of Science and Technology (212102310117);Project Jointly Built of Provincial Department by Henan Provincial Health Commission (SB201901106);Project Jointly Built by Henan Provincial Health Commission (LHGJ20200158)

Corresponding Authors: Li Dingjie, Email:150304089@qq.com

Cite this article:

Liu Yang,Ding Danhong,Wei Shengtao et al. Exploration of the application of half-field intensity-modulated irradiation technique in the radiotherapy for esophageal cancer[J]. Chinese Journal of Radiation Oncology, 2022, 31(1): 65-70.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.cn113030-20210906-00352 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2022/V31/I1/65

[1] AJANI JA, D`AMICO TA, BENTREM DJ, et al. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology[J]. J NatIComprCancNetw, 2019, 17(7):855-883. DOI:10.6004/jnccn.2019.0033.
[2] DENG W, LIN SH. Advances in radiotherapy for esophageal can-cer[J]. Ann Transl Med, 2018,6(4):79. DOI:10.21037/atm.2017.11.28
[3] SUH YG, LEE IJ, KOOM,WS, et al. High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages Ⅱ-Ⅲ esophageal cancer[J]. Jpn J Clin Oncol, 2014, 44(6):534-540. DOI:10.1093/jjco/hyu047.
[4] TONISON JJ, FISCHER SG, VIEHRIG,et alRadiation pneumonitis after intensity-modulated radiotherapy for esophageal cancer:institutional data and a systematic review[J]. Sci Rep, 2019, 9(1):2255. DOI:10.1038/s41598-018-38414-5.
[5] 孔月,徐裕金,陈梦圆,等. 胸段食管癌患者三种放疗计划心脏和肺的剂量学比较[J]. 中华放射医学与防护杂志,2017, 37(11):832-837. DOI:10.3760/cma.j.issn.0254-5098.2017.11.006.
KONG Y, XU YJ, CHEN MY,et al. Dossiological comparison of heart and lung in three radiotherapy programs in patients with thoracic segment esophageal cancer[J]. Chin J Radiol Med Protect, 2017, 37(11):832-837. DOI:10.3760/cma.j.issn.0254-5098.2017.11.006.
[6] AHMED S, NELMS B, GINTZ D, et al. A method for a priori estimation of best feasible DVH for organs at risk:Validation for head and neck VMAT planning[J]. Med Phys, 2017, 44(10):5486-5497. DOI:10.1002/mp.12500.
[7] KLEIN EE, HANLEY J, BAYOUTH J, et al. Task Group 142 report:quality assurance of medical accelerators[J]. Med Phys, 2009, 36(9):4197-4212. DOI:10.1118/1.3190392.
[8] SHAIKH T, CHURILLA TM, MONPARA P, et al. Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancer[J]. PractRadiat Oncol, 2016, 6(6):388-394. DOI:10.1016/j.prro.2016.02.004.
[9] NOMURA M, KODAIRA T, FURUTANI K, et al. Predictive factors for radiation pneumonitis in oesophageal cancer patients treated with chemoradiotherapy without prophylactic nodal irradiation[J]. BrJRadiol, 2012, 85(1014):813-818. DOI:10.1259/bjr/13604628.
[10] 杜峰,王强,王玮,等. 胸段食管癌放疗后放射性肺炎相关因素分析[J]. 中华放射医学与防护杂志,2020, 40(11):832-839. DOI:10.3760/cma.j.issn.0254-5098.11.004.
DU F, WANG Q, WANG W, et al. Analysis of factors associated with radiation pneumonia after radiotherapy for thoracic segment esophageal cancer[J]. Chin J Radiol Med Protect, 2020, 40(11):832-839. DOI:10.3760/cma.j.issn.0254-5098.11.004.
[11] CHARGARI C, RIET F, MAZEVET M, et al. Complications of thoracic radiotherapy[J]. Presse Med, 2013, 42(9 Pt 2):e342-351. DOI:10.1016/j.lpm.2013.06.012.
[12] LUNA JM, CHAO HH, DIFFENDERFER ES, et al. Predicting radiation pneumonitis in locally advanced stage Ⅱ-Ⅲ non-small cell lung cancer using machine learning[J]. Radiother Oncol, 2019, 133:106-112. DOI:10.1016/j.radonc.2019.01.003.
[13] BLOM-GOLDMAN U, WENNBERG B, SVANE G, et al. Reduction of radiation pneumonitis by V20-constraints in breast cancer[J]. Radiat Oncol, 2010, 5:99. DOI:10.1186/1748-717X-5-99.
[14] GOPAL R, TUCKER SL, KOMAKI R, et al. The relationship between local dose and loss of function for irradiated lung[J]. Int JRadiat Oncol Biol Phys, 2003, 56(1):106-113. DOI:1 0.1016/s0360-3016(03)00094-4.
[15] 沈文斌,祝淑钗,高红梅,等. 肺脏低剂量区体积预测食管癌三维适形放疗所致急性放射性肺炎的价值[J]. 中华肿瘤杂志,2013, 35(1):45-49. DOI:10.3760/cma.j.issn.0253-3766.2013.01.010.
SHEN WB, ZHU SC, GAO HM, et al. Value of lung low-dose area volume in predicting acute radiation pneumonia caused by three-dimensional conformal radiation therapy in esophageal cancer[J]. Chin J Oncol, 2013, 35(1):45-49. DOI:10.3760/cma.j.issn.0253-3766.2013.01.010.
[16] LIN SH, WANG L, MYLES B, et al. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy for esophageal cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 84(5):1078-1085. DOI:10.1016/j.ijrobp.2012.02.015.
[17] 刘志强,胡志辉,戴建荣. 动态钨门技术在中段食管癌螺旋断层调强放疗中的应用[J]. 中华放射医学与防护杂志,2019, 39(1):63-67. DOI:10.3760/cma.j.issn.0254-5098.2019.01.012.
LIU ZQ, HU ZH, DAI JR. Application of dynamic tungsten gate technology in IMRT of middle esophageal cancer[J]. Chin J Radiol Med Protect, 2019, 39(1):63-67. DOI:10.3760/cma.j.issn.0254-5098.2019.01.012.
[18] WIJESOORIYA K. Part I:out-of-field dose mapping for 6Xand 6X-flattening-filter-free beams on the TrueBeam for extended distances[J]. Med Phys, 2019, 46(2):868-876. DOI:10.1002/mp.13362.
[19] 李定杰,张有改,薛莹,等. 早期NSCLC无均整器模式VMAT计划剂量比较研究[J]. 中华放射肿瘤学杂志,2017, 26(1):53-56. DOI:10.3760/cma.j.issn.1004-4221.2017.01.012.
LI DJ, ZHANG YG, XUE Y,et al. Early NSCLC Amode VMAT planned dose comparison study[J]. Chin J Radiat Oncol, 2017, 26(1):53-56. DOI:10.3760/cma.j.issn.1004-4221.2017.01.012.
[20] 贺先桃,谭军文,龙雨松,等. 鼻咽癌FFF与FF模式下VMAT计划剂量学比较[J]. 中华放射肿瘤学杂志,2018, 27(4):401-405. DOI:10.3760/cma.j.issn.1004-4221.2018.04.014.
HE XT, TAN JW, LONG YS,et al. Planned dosisiological comparison of VMAT in NPC FFF versus FF mode[J]. Chin J Radiat Oncol, 2018, 27(4):401-405. DOI:10.3760/cma.j.issn.1004-4221.2018.04.014.
[21] LAI Y, CHEN Y, WU S, et al. Modified volumetric modulated arc therapy in left sided breast cancer after radical mastectomy with flattening filter free versus flattened beams[J]. Medicine (Baltimore), 2016, 95(14):e3295. DOI:10.1097/MD. 0000000000003295.